Literature DB >> 24242756

Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.

R E Kast1, B M Ellingson, C Marosi, M-E Halatsch.   

Abstract

We present here a potential new treatment adjunct for glioblastoma. Building on murine studies, a series of papers appeared recently showing that therapeutic irradiation of the ipsilateral subventricular zone (SVZ) retards growth of more peripherally growing cortical glioblastomas in humans, suggesting a tumor trophic function for the SVZ. Further studies showed that SVZ cells migrate out towards a peripheral glioblastoma. Dopamine signaling through D3 subtype receptor indirectly drives this centrifugal migration in humans. Since psychiatry has several drugs with good D3 blocking attributes, such as fluphenazine, or perphenazine, we suggest that adding one of these D3 blocking drugs to current standard treatment of resection followed by temozolomide and irradiation might prolong survival by depriving glioblastoma of the trophic functions previously subserved by dopaminergic signaling on SVZ cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242756     DOI: 10.1007/s11060-013-1308-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  45 in total

1.  Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Whitney B Pope; Taryar M Zaw; Heidi Phillips; Shadi Lalezari; Phioanh L Nghiemphu; Hassana Ibrahim; Kourosh M Naeini; Robert J Harris; Albert Lai
Journal:  Neuroimage       Date:  2011-10-07       Impact factor: 6.556

2.  Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor.

Authors:  Yongsoo Kim; Wei-Zhi Wang; Isabelle Comte; Erika Pastrana; Phuong B Tran; Jennifer Brown; Richard J Miller; Fiona Doetsch; Zoltán Molnár; Francis G Szele
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

3.  Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonists.

Authors:  Richard E Kast
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

4.  Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.

Authors:  Percy Lee; Wietse Eppinga; Frank Lagerwaard; Timothy Cloughesy; Benjamin Slotman; Phioanh L Nghiemphu; Pin-Chieh Wang; Patrick Kupelian; Nzhde Agazaryan; John Demarco; Michael T Selch; Michael Steinberg; Jung Julie Kang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-22       Impact factor: 7.038

5.  Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture.

Authors:  B J Vilner; W D Bowen
Journal:  Eur J Pharmacol       Date:  1993-01-15       Impact factor: 4.432

Review 6.  Efficacy of perphenazine to prevent postoperative nausea and vomiting: a quantitative systematic review.

Authors:  Alexander Schnabel; Leopold H Eberhart; Ralf Muellenbach; Astrid M Morin; Norbert Roewer; Peter Kranke
Journal:  Eur J Anaesthesiol       Date:  2010-12       Impact factor: 4.330

7.  Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.

Authors:  Linda Chen; Hugo Guerrero-Cazares; Xiaobu Ye; Eric Ford; Todd McNutt; Lawrence Kleinberg; Michael Lim; Kaisorn Chaichana; Alfredo Quinones-Hinojosa; Kristin Redmond
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-26       Impact factor: 7.038

8.  Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection.

Authors:  Jérôme Kroonen; Jessica Nassen; Yves-Gautier Boulanger; Fabian Provenzano; Valérie Capraro; Vincent Bours; Didier Martin; Manuel Deprez; Pierre Robe; Bernard Rogister
Journal:  Int J Cancer       Date:  2010-11-23       Impact factor: 7.396

9.  Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.

Authors:  Patrick Evers; Percy P Lee; John DeMarco; Nzhde Agazaryan; James W Sayre; Michael Selch; Frank Pajonk
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

10.  Response of psychotic depression subtypes to pharmacotherapy.

Authors:  R F Anton; E A Burch
Journal:  J Affect Disord       Date:  1993-06       Impact factor: 4.839

View more
  9 in total

Review 1.  Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma.

Authors:  Andrew W Smith; Minesh P Mehta; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2016-04-23       Impact factor: 4.130

Review 2.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

3.  Subventricular zone-associated glioblastoma: A call for translational research to guide clinical decision making.

Authors:  Andrew W Smith; Bhupesh Parashar; A Gabriella Wernicke
Journal:  Neurogenesis (Austin)       Date:  2016-08-19

Review 4.  New considerations in radiation treatment planning for brain tumors: neural progenitor cell-containing niches.

Authors:  Carmen Kut; Kristin Janson Redmond
Journal:  Semin Radiat Oncol       Date:  2014-10       Impact factor: 5.934

5.  Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.

Authors:  Cornelia M Hooper; Susan M Hawes; Ursula R Kees; Nicholas G Gottardo; Peter B Dallas
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

6.  Precise medication for tumor patients in the context of mental stress.

Authors:  Qi-Shun Geng; Zhi-Bo Shen; Yuan-Yuan Zheng; Wen-Hua Xue; Li-Feng Li; Jie Zhao
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  Perphenazine and prochlorperazine decrease glioblastoma U-87 MG cell migration and invasion: Analysis of the ABCB1 and ABCG2 transporters, E-cadherin, α-tubulin and integrins (α3, α5, and β1) levels.

Authors:  Michał Otręba; Jerzy Stojko; Agata Kabała-Dzik; Anna Rzepecka-Stojko
Journal:  Oncol Lett       Date:  2022-04-15       Impact factor: 3.111

Review 8.  Neurotransmitters: Potential Targets in Glioblastoma.

Authors:  Qiqi Huang; Lishi Chen; Jianhao Liang; Qiongzhen Huang; Haitao Sun
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

Review 9.  Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.

Authors:  Safwan Alomari; Irma Zhang; Adrian Hernandez; Caitlin Y Kraft; Divyaansh Raj; Jayanidhi Kedda; Betty Tyler
Journal:  Biomolecules       Date:  2021-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.